Clinical Trial: Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Observational

Official Title: Studies of Plasma Proteins Derived From Pulmonary Arteriovenous Malformation Patients

Brief Summary: Hereditary Haemorrhagic Telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome) is an disease that leads to the development of dilated and fragile blood vessels, including arteriovenous malformations in the lungs (PAVMs). We hypothesize that the genetically-determined abnormality in the blood vessels of HHT patients leads to alteration in the concentrations or activity of several proteins in the blood stream. We propose to take blood samples from patients at defined times in order to study changes in blood protein levels and activity

Detailed Summary:
Sponsor: Imperial College London

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Imperial College London

Dates:
Date Received: September 29, 2005
Date Started: March 2005
Date Completion:
Last Updated: August 12, 2008
Last Verified: August 2008